Home
Search
Agriculture & Environment

Addressing Climate Change

Addressing Climate Change Challenges Through Biotechnology

There are more than 5 trillion pieces of plastic floating in our oceans. The U.S. transportation sector leads all other sectors in greenhouse gas emissions. Diseases that thrive in hot weather are killing important staple crops. Our reliance on products derived from fossil fuels is harming our planet.

Climate change is real but through biotechnology, we can meet these challenges head-on by making the same reliable plastics, foods, and fuels with less environmental impact.

Addressing Climate Change
Strengthening the Bioeconomy
Growing Trust in Innovation
Stay Informed. Current News in the Ag & Environment Sector
AG BLOG

Climate Change Efforts in the Industry

Explore Latest News
AG BLOG 2

Ag & Environment Efforts in the Industry

Explore Latest News
Press Releases
Browse all Press Releases
ORPHAN Cures Act a "welcome and bipartisan fix" to the IRA's negative impact on drug development
September 18, 2023
Representatives John Joyce, M.D. (R-PA) and Wiley Nickel (D-NC) today introduced the Optimizing Research Progress Hope And New Cures (ORPHAN Cures Act). BIO President and CEO, Rachel King, made the following remarks: "This legislation is a welcome and bipartisan fix to the Inflation Reduction Act…
BIO Honors Biotech Leaders for Breakthroughs in Ag & Environment Biotech
September 12, 2023
The Biotechnology Innovation Organization has honored two biotechnology leaders who are driving cutting-edge breakthroughs in agricultural, environmental and industrial biotechnology. Dr. Pam Marrone, Co-founder and Executive Chair of Invasive Species Corp., is the recipient of the Rosalind…
BIO Applauds FTC Settlement Decision
September 1, 2023
Yesterday the Federal Trade Commission (FTC) announced the decision to settle its Amgen-Horizon merger challenge. The settlement will give the Commission the relief it needs to protect competition, while allowing rare disease patients to enjoy the deal's pro-competitive benefits without delay. BIO…
Good Day BIO Newsletter
Subscribe to GoodDay BIO

Receive the best resource for the biotech industry with Good Day BIO, the only daily newsletter at the intersection of biotech, politics and policy. 

Subscribe
Letters, Comments & Testimony
Browse all Letters, Comments & Testimony
Testimony of John F. Crowley, Executive Chairman of Amicus Therapeautics, to the House Committee on Energy and Commerce Subcommittee on Oversight and Investigations  for the hearing “How the IRA’s Price Setting Scheme Means Fewer Cures for Patients”
September 20, 2023
BIO Board Vice Chair and CEO of Amicus Therapeutics testified that the drug price controls in the Inflation Reduction Act harm drug research and development.
Coalition Letter Supporting Ag Research Funding
September 11, 2023
BIO joined with other groups in writing House and Senate Agriculture Committee leaders in support of agricultural research (FFAR) funding in the farm bill. 
BIO Comments to FDA on Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products
August 3, 2023
In response to the agency's request for information (Docket No. FDA-2023-N-0743-0002), BIO provides detailed comments.